Patients who have been identified to be at low risk of liver fibrosis and have not had a specific liver disease diagnosed on a liver aetiological screen, can be safely managed in primary care. The majority of these individuals will have abnormal liver blood tests is relation to alcohol consumption or excess body weight, so management should be targeted accordingly.

It has also been shown that these patients are at higher risk of type II diabetes and cardiovascular complications in the future, and therefore these risks should also be addressed in primary care.

Patients should be followed up via repeat assessment of the AST:ALT ratio every 4-years, to check for increasing risk of liver fibrosis.